BPTHBIO-PATH HOLDINGS INC

Nasdaq biopathholdings.com


$ 2.58 $ 0.02 (0.78 %)    

Tuesday, 14-May-2024 14:04:41 EDT
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 2.58
$ 2.58
$ 0.00 x 0
$ 0.00 x 0
$ 2.58 - $ 2.58
$ 2.35 - $ 44.80
67,342
na
1.67M
$ 0.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-07-2024 12-31-2023 10-K
3 08-14-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-10-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-09-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-14-2020 03-31-2020 10-Q
17 03-05-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-15-2019 03-31-2019 10-Q
21 03-19-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 04-02-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 03-15-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 03-15-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-11-2015 03-31-2015 10-Q
37 03-16-2015 12-31-2014 10-K
38 11-14-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-15-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bio-path-holdings-has-been-granted-israeli-patent-number-269608-titled-compositions-comprising-p-ethoxy-nucleic-acids-for-stat3-inhibition-for-use-in-treating-cancer-or-autoimmune-disease

https://israelpatents.justice.gov.il/search/en/patent-extract/269608

 bio-path-holdings-announces-12m-registered-direct-offering-with-some-institutional-investors-for-sale-of-375000-shares-of-its-common-stock-at-price-of-3225share

Bio-Path Holdings, Inc., (NASDAQ:BPTH) (the "Company" or "Bio-Path"), a biotechnology company leveraging its pr...

 roth-mkm-reiterates-buy-on-bio-path-hldgs-maintains-40-price-target

Roth MKM analyst Philip Shen reiterates Bio-Path Hldgs (NASDAQ:BPTH) with a Buy and maintains $40 price target.

 why-bio-path-stock-is-soaring
Why Bio-Path Stock Is Soaring
04/18/2024 16:40:52

Bio-Path Holdings shares are trading higher Thursday after the company announced the completion of its second dose cohort in Ph...

 dow-surges-over-100-points-dr-horton-posts-upbeat-earnings

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market...

Core News & Articles
Market-Moving News for April 18th
04/18/2024 12:35:31

BPTH: 98% | Bio-Path Holdings shares are trading higher after the company announced the completion of its second dose cohort in...

 bio-path-holdings-reveals-receipt-of-newly-issued-patents-in-mexico-australia-and-japan

Bio-Path has expanded its intellectual property portfolio by filing patent applications that are applicable to its technology a...

 bio-path-holdings-said-may-offer-and-sell-up-to-2m-of-common-stock-from-time-to-time-through-hc-wainwright-entered-into-at-market-offering-agreement-relating-to-shares-of-common-stock-offered-by-prospectus-supplement

-8-K/424B5

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION